On-going Dual and Triple Agonists Phase 3 Trials on Metabolic Liver Diseases

Created using ChatSlide

Explore the cutting-edge advancements in metabolic liver disease management at our upcoming EduWorkshop. This session will delve into the mechanisms of dual and triple agonists, examining their roles in liver metabolism and their potential to transform current therapies. Gain insights from Phase 3 trials and recent studies, highlighting efficacy and safety data. We'll discuss real-world clinical implications, address regulatory challenges, and explore the future of personalised therapies and...